Abstract

Omeprazole 2-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2006 - Dermatology

Page(s): 389

Download in electronic PDF format for $75
  • Omeprazole 2-mg/mL Oral Liquid Page 1

Abstract

A formulation for preparing Omeprazole 2-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • omeprazole
  • gastrointestinal disorders
  • peptic ulcers
  • stomach acid
  • proton pump inhibitor
  • gastroesophageal reflux disease
  • GERD
  • hypersecretory disorders
  • gastrointestinal bleeding

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2006
Pg. 389
Omeprazole 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 124-128
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A
Jan/Feb 2019
Pg. 58
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 504-510
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Sep/Oct 2006
Pg. 391
Pantoprazole Sodium 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 500-512
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
May/Jun 2023
Pg. 250-255
Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base
Author(s): Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2020
Pg. 140-147
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Author(s): Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
Mar/Apr 2010
Pg. 171-173
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Sep/Oct 2006
Pg. 382
Famotidine 8-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 164-166
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted)
Author(s): Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2007
Pg. 161
Ranitidine Hydrochloride 15-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 117-124
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Author(s): Zur Eyal
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 409
Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Author(s): Allen Loyd V Jr
Nov/Dec 2005
Pg. 423-431
Compounding for a Pediatric Hospital
Author(s): McElhiney Linda F
May/Jun 2010
Pg. 246
Lansoprazole 3-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2006
Pg. 139
Cimetidine 60-mg/mL Oral Liquid, Alcohol Free
Author(s): Allen Loyd V Jr